76 Views
Tuesday Poster Session
Category: Esophagus
Kenneth Wang, MD
Mayo Clinic
Rochester, MN, United States
| FOCAL Cohort, n=75 | MP Cohort, n=64 | P Value |
Male sex (n) | 61 | 56 | 0.71 |
Age (y) | 63.7±8.5 | 62.3±10.5 | 0.46 |
Mean BE length (cm) | 5±3 | 6±4 | 0.43 |
Use of twice daily PPI dose (n) | 53 | 44 | 0.22 |
Mean hiatal hernia size | 3±2 | 3±2 | 0.90 |
Initial BE histology (n) |
| 0.32 | |
Adenocarcinoma | 9 | 9 |
|
High grade dysplasia | 27 | 28 | |
Low grade dysplasia | 14 | 15 | |
Non-dysplastic BE | 23 | 12 | |
Median number of RFA treatments prior to focal completion ablation therapy (IQR) | 3 (IQR 25-75: 2-5) | 2 (IQR 25-75:1-3) | 0.22 |